| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $773,535 | 15 | 100 |
Sells | $0 | 0 | 0 |
| ALAM JOHN J | CEO & President | 4 | $282,652 | 0 | $0 | $282,652 |
| Gregoire Sylvie | 4 | $282,652 | 0 | $0 | $282,652 | |
| Winton Matthew | Chief Commercial and Business | 3 | $117,130 | 0 | $0 | $117,130 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary | 4 | $91,101 | 0 | $0 | $91,101 |
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
Over the last 12 months, insiders at CervoMed Inc. have bought $773,535 and sold $0 worth of CervoMed Inc. stock.
On average, over the past 5 years, insiders at CervoMed Inc. have bought $395,847 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: ALAM JOHN J (CEO & President) — $282,652. Gregoire Sylvie () — $282,652. Winton Matthew (Chief Commercial and Business) — $117,130.
The last purchase of 1,500 shares for transaction amount of $11,925 was made by Winton Matthew (Chief Commercial and Business) on 2025‑11‑18.
| 2025-11-18 | Winton Matthew | Chief Commercial and Business | 1,500 0.0155% | $7.95 | $11,925 | -2.41% | ||
| 2025-11-18 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | 2,500 0.0271% | $8.32 | $20,800 | -2.41% | ||
| 2025-11-17 | Gregoire Sylvie | 21,600 0.2406% | $8.46 | $182,736 | -1.10% | |||
| 2025-11-17 | ALAM JOHN J | CEO & President | 21,600 0.2406% | $8.46 | $182,736 | -1.10% | ||
| 2025-11-17 | Winton Matthew | Chief Commercial and Business | 3,500 0.0388% | $8.43 | $29,505 | -1.10% | ||
| 2025-11-17 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | 1,000 0.0111% | $8.45 | $8,450 | -1.10% | ||
| 2025-11-14 | Gregoire Sylvie | 3,400 0.0383% | $7.56 | $25,704 | +6.18% | |||
| 2025-11-14 | ALAM JOHN J | CEO & President | 3,400 0.0383% | $7.56 | $25,704 | +6.18% | ||
| 2025-11-14 | Winton Matthew | Chief Commercial and Business | 10,000 0.1128% | $7.57 | $75,700 | +6.18% | ||
| 2025-11-13 | Gregoire Sylvie | 4,447 0.0498% | $7.51 | $33,397 | +12.00% | |||
| 2025-11-13 | ALAM JOHN J | CEO & President | 4,447 0.0498% | $7.51 | $33,397 | +12.00% | ||
| 2025-11-12 | Gregoire Sylvie | 5,553 0.0637% | $7.35 | $40,815 | +9.31% | |||
| 2025-11-12 | ALAM JOHN J | CEO & President | 5,553 0.0637% | $7.35 | $40,815 | +9.31% | ||
| 2025-11-12 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | 3,500 0.0407% | $7.44 | $26,040 | +9.31% | ||
| 2025-05-14 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | 4,233 0.0495% | $8.46 | $35,811 | -2.82% | ||
| 2024-08-27 | ELDER WILLIAM ROBERT | CFO & GC | 1,000 0.0132% | $18.16 | $18,160 | -47.33% |
| Increased Positions | 20 | +31.25% | 216,685 | +10.03% |
| Decreased Positions | 29 | -45.31% | 240,080 | -11.11% |
| New Positions | 14 | New | 161,879 | New |
| Sold Out Positions | 11 | Sold Out | 158,166 | Sold Out |
| Total Postitions | 55 | -14.06% | 2M | -1.08% |
| Awm Investment Company, Inc. | $6,724.00 | 9.59% | 863,200 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $3,225.00 | 4.6% | 414,037 | +38,747 | +10.32% | 2025-09-30 |
| Vanguard Group Inc | $2,676.00 | 3.82% | 343,463 | +3,445 | +1.01% | 2025-09-30 |
| Millennium Management Llc | $557.00 | 0.8% | 71,509 | -4,571 | -6.01% | 2025-09-30 |
| Geode Capital Management, Llc | $502.00 | 0.72% | 64,467 | +10,211 | +18.82% | 2025-09-30 |
| Blackrock, Inc. | $380.00 | 0.54% | 48,832 | -55,217 | -53.07% | 2025-09-30 |
| Citadel Advisors Llc | $238.00 | 0.34% | 30,510 | +30,510 | New | 2025-09-30 |
| Perigon Wealth Management, Llc | $224.00 | 0.32% | 28,731 | +11,425 | +66.02% | 2025-09-30 |
| Cetera Investment Advisers | $214.00 | 0.31% | 27,440 | +27,440 | New | 2025-09-30 |
| Avantax Advisory Services, Inc. | $203.00 | 0.29% | 26,087 | +103 | +0.4% | 2025-06-30 |